Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples